Vaginal Laser treatments are becoming increasing available in the community and have been touted as a less invasive treatment for a variety of female conditions including vaginal dryness due to menopause, vaginal laxity, sexual function, and urinary incontinence. Overall, there is a lack of high quality scientific data to support these claims. Additionally the potential long term complications, safety and effectiveness of these techniques is poorly understood. The FDA has recently warned that these procedures have not been approved for the treatment of any vaginal conditions, and in 2018 issued a safety warning against their use (INSERT LINK). The purpose of that communication is to alert patients that the safety and effectiveness of vaginal laser or “rejuvenation” procedures has not been established, and may be associated with serious adverse events. This opinion is currently supported by the American College of Obstetrician and Gyncologists.
The International Urogynecological Association recently formed a committee to explore the evidence for the use of intravaginal lasers to treat conditions such as vaginal laxity and stress urinary incontinence. (Disclosure, Dr Toglia is currently on the editorial board of this journal). This committee opinion was recently published in 2019. While the committee acknowledges that there is an urgent need for large randomized control trials, it concluded that there is insufficient data to support the its use for the treatment of vaginal laxity or stress incontinence. The guidelines also noted that such therapy is often associated with a high cost to patients. The guidelines concluded that laser therapy should not be used to treat these conditions in the absence of strong scientific evidence.
The providers of Urogynecology Associates of Philadelphia welcome women to make an appointment to discuss conditions such as vaginal laxity, prolapse and urinary incontinence, and to learn about current recommended treatment options.
CLICK HERE to read the full statement from the FDA